Form 4 for CSW CSW INDUSTRIALS, INC.
Accepted 2026-04-07 17:30:49 ET · period of report 2026-04-02 · accession 0001668461-26-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-04-07 17:30 | 2026-04-02 | CSW | Alverson Luke | SVP, GC, Sec | M - OptEx | $0.00 | +3,347 | 15.8K | +27% | $0 |
| DT | 2026-04-07 17:30 | 2026-04-02 | CSW | Alverson Luke | SVP, GC, Sec | F - Tax | $260.34 | -1,333 | 14.5K | -8% | -$347.0K |
| DT | 2026-04-07 17:30 | 2026-04-07 | CSW | Alverson Luke | SVP, GC, Sec | S - Sale+OE | $266.11 | -1,007 | 13.5K | -7% | -$268.0K |
| DT | 2026-04-07 17:30 | 2026-04-02 | CSW | Alverson Luke | SVP, GC, Sec | M - OptEx | $0.00 | -1,731 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-04-02 | M | A | 3,347 | $0.00 | 15,797 | D | — | — | (F1) Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate between 0% and 200% during a three-year performance cycle ending on March 31, 2026 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights, along with 24 dividend equivalent units, vested at 190.7% of the target award amount and were settled in shares of common stock pursuant to the award agreement terms. |
| 2 | Common | Common Stock | 2026-04-02 | F | D | 1,333 | $260.34 | 14,464 | D | — | — | |
| 3 | Common | Common Stock | 2026-04-07 | S | D | 1,007 | $266.11 | 13,457 | D | — | — | (F2) The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on December 1, 2025. (F3) The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $264.0500 to $268.8369, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. |
| 4 | Derivative | Performance Rights | 2026-04-02 | M | D | 1,731 | $0.00 | 0 | D | — · — to — | 1,731 Common Stock | (F1) Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate between 0% and 200% during a three-year performance cycle ending on March 31, 2026 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights, along with 24 dividend equivalent units, vested at 190.7% of the target award amount and were settled in shares of common stock pursuant to the award agreement terms. (F1) Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate between 0% and 200% during a three-year performance cycle ending on March 31, 2026 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights, along with 24 dividend equivalent units, vested at 190.7% of the target award amount and were settled in shares of common stock pursuant to the award agreement terms. (F1) Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate between 0% and 200% during a three-year performance cycle ending on March 31, 2026 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights, along with 24 dividend equivalent units, vested at 190.7% of the target award amount and were settled in shares of common stock pursuant to the award agreement terms. |